Dechra Pharmaceuticals PLC Director/PDMR Shareholding (6654C)

TIDMDPH

RNS Number : 6654C

Dechra Pharmaceuticals PLC

20 October 2020

20 October 2020

Dechra(R) Pharmaceuticals PLC

(Dechra or the Company)

LEI: 213800J4UVB5OWG8VX82

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

Grant of SAYE options:

Dechra Pharmaceuticals PLC announces that on 19 October 2020 the following PDMRs were granted options over ordinary shares of 1p each in the Company pursuant to the Dechra Global Save As You Earn Plan 2018 (the Options).

The Options have been granted with an exercise price of GBP28.68.

 
 Name             Capacity    Options Granted 
 Ian Page         Director    627 
 Paul Sandland    Director    627 
 

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                  Ian Page 
     ------------------------------------  ------------------------------------------- 
 2.   Reason for the notification 
     --------------------------------------------------------------------------------- 
 a)   Position/status                       Director/PDMR 
     ------------------------------------  ------------------------------------------- 
 b)   Initial notification/                 Initial Notification 
       amendment 
     ------------------------------------  ------------------------------------------- 
 3.   Details of the Issuer 
     --------------------------------------------------------------------------------- 
 a)   Name                                  Dechra Pharmaceuticals PLC 
     ------------------------------------  ------------------------------------------- 
 b)   LEI code                              213800J4UVB5OWG8VX82 
     ------------------------------------  ------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     --------------------------------------------------------------------------------- 
 a)   Description of                        Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                             ISIN: GB0009633180 
       Identification 
       code 
     ------------------------------------  ------------------------------------------- 
 b)   Nature of the                         Grant of 627 options under the Company's 
       transaction                           Save As You Earn Scheme 
     ------------------------------------  ------------------------------------------- 
 c)   Price(s) and volumes(s)               Price(s)               Volume(s) 
                                             GBP28.68               627 
     ------------------------------------  ---------------------  -------------------- 
 d)        Aggregated information 
             *    Aggregate volume 
                                              627 
                                              GBP17,982.36 
             *    Price 
     ------------------------------------  ------------------------------------------- 
 e)   Date of the transaction               2020.10.19 
     ------------------------------------  ------------------------------------------- 
 f)   Place of the transaction              Outside a trading venue 
     ------------------------------------  ------------------------------------------- 
 
 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                  Paul Sandland 
     ------------------------------------  ------------------------------------------- 
 2.   Reason for the notification 
     --------------------------------------------------------------------------------- 
 a)   Position/status                       Director/PDMR 
     ------------------------------------  ------------------------------------------- 
 b)   Initial notification/                 Initial Notification 
       amendment 
     ------------------------------------  ------------------------------------------- 
 3.   Details of the Issuer 
     --------------------------------------------------------------------------------- 
 a)   Name                                  Dechra Pharmaceuticals PLC 
     ------------------------------------  ------------------------------------------- 
 b)   LEI code                              213800J4UVB5OWG8VX82 
     ------------------------------------  ------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     --------------------------------------------------------------------------------- 
 a)   Description of                        Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                             ISIN: GB0009633180 
       Identification 
       code 
     ------------------------------------  ------------------------------------------- 
 b)   Nature of the                         Grant of 627 options under the Company's 
       transaction                           Save As You Earn Scheme 
     ------------------------------------  ------------------------------------------- 
 c)   Price(s) and volumes(s)               Price(s)               Volume(s) 
                                             GBP28.68               627 
     ------------------------------------  ---------------------  -------------------- 
 d)        Aggregated information 
             *    Aggregate volume 
                                              627 
                                              GBP17,982.36 
             *    Price 
     ------------------------------------  ------------------------------------------- 
 e)   Date of the transaction               2020.10.19 
     ------------------------------------  ------------------------------------------- 
 f)   Place of the transaction              Outside a trading venue 
     ------------------------------------  ------------------------------------------- 
 

For further information, please contact:

Melanie Hall, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHKKKBPKBDDCKB

(END) Dow Jones Newswires

October 20, 2020 07:01 ET (11:01 GMT)